​
​

LAVA Therapeutics (LVTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

LAVA Therapeutics Revenue Highlights

Latest Revenue (Y)

$6.77M

Latest Revenue (Q)

$6.99M

LAVA Therapeutics Revenue by Period

LAVA Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--65.09%
2022-12-31-287.82%
2021-12-31-27.60%
2020-12-31-100.00%
2019-12-31--

LAVA Therapeutics generated $6.77M in revenue during NA 2023, up -65.09% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

LAVA Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31-1880.74%
2023-12-31-566.04%
2023-09-30--98.97%
2023-06-30-319.85%
2023-03-31--53.64%
2022-12-31--82.70%
2022-09-30-3160.90%
2022-06-30--53.20%
2022-03-31--
2021-12-31--51.59%
2021-09-30-93.53%
2021-06-30--1.13%
2021-03-31--52.07%
2020-12-31-132.01%
2020-09-30-45.83%
2020-06-30-100.00%
2020-03-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

LAVA Therapeutics generated $6.99M in revenue during Q1 2024, up 1880.74% compared to the previous quarter, and up 264.85% compared to the same period a year ago.

LAVA Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADAGAdagene--
IKNAIkena Oncology--
ASMBAssembly Biosciences--
LVTXLAVA Therapeutics--
KRONKronos Bio--
GBIOGeneration Bio--
ANEBAnebulo Pharmaceuticals--
DSGNDesign Therapeutics--
RZLTRezolute--
BNOXBionomics--
CCCCC4 Therapeutics--
ANTXAN2 Therapeutics--
AVTEAerovate Therapeutics--
NXTCNextCure--
TILInstil Bio--
ERASErasca--
ELYMEliem Therapeutics--
NLTXNeurogene--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--
ACHLAchilles Therapeutics--
EWTXEdgewise Therapeutics--
XLOXilio Therapeutics--

LVTX Revenue FAQ

What is LAVA Therapeutics’s yearly revenue?

LAVA Therapeutics's yearly revenue for 2023 was $6.77M, representing a decrease of -65.09% compared to 2022. The company's yearly revenue for 2022 was $19.39M, representing an increase of 287.82% compared to 2021. LVTX's yearly revenue for 2021 was $5M, representing an increase of 27.60% compared to 2020.

What is LAVA Therapeutics’s quarterly revenue?

LAVA Therapeutics's quarterly revenue for Q1 2024 was $6.99M, a 1880.74% increase from the previous quarter (Q4 2023), and a 471.24% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $353K, a 566.04% increase from the previous quarter (Q3 2023), and a -86.63% decrease year-over-year (Q4 2022). LVTX's quarterly revenue for Q3 2023 was $53K, a -98.97% decrease from the previous quarter (Q2 2023), and a -99.65% decrease year-over-year (Q3 2022).

What is LAVA Therapeutics’s revenue growth rate?

LAVA Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 35.38%, and for the last 5 years (2019-2023) was 0%.